| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |